A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat.
Antidepressive agent
Clinical outcome
Depressive disorder
Treatment
Treatment-resistance
Journal
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
ISSN: 1738-1088
Titre abrégé: Clin Psychopharmacol Neurosci
Pays: Korea (South)
ID NLM: 101207332
Informations de publication
Date de publication:
28 Feb 2021
28 Feb 2021
Historique:
received:
04
03
2020
accepted:
13
03
2020
entrez:
28
1
2021
pubmed:
29
1
2021
medline:
29
1
2021
Statut:
ppublish
Résumé
We report the results of pharmacogenomics-based antidepressant treatment (PGXt) results in treating treatment-resistant major depressive disorder (TRD) patients in real practice. Nine patients were prescribed Neuropharmagen After treatment by PGXt results from current antidepressants, substantial reduction of depressive symptoms was observed at some point and maintained during observation period in six patients. Our case series potentially shows the clinical utility and benefit of PGXt for treatment of TRD patients.
Identifiants
pubmed: 33508800
pii: cpn.2021.19.1.160
doi: 10.9758/cpn.2021.19.1.160
pmc: PMC7851455
doi:
Types de publication
Journal Article
Langues
eng
Pagination
160-165Références
J Psychiatr Res. 2018 Jan;96:100-107
pubmed: 28992526
Clin Psychopharmacol Neurosci. 2017 Aug 31;15(3):199-209
pubmed: 28783928
Expert Opin Investig Drugs. 2015 Apr;24(4):445-53
pubmed: 25529224
CNS Drugs. 2013 May;27 Suppl 1:S29-37
pubmed: 23709359
BMC Psychiatry. 2017 Jul 14;17(1):250
pubmed: 28705252
J Affect Disord. 2018 Dec 1;241:484-491
pubmed: 30149336
CNS Spectr. 2017 Aug;22(4):315-324
pubmed: 27098095
Expert Opin Drug Metab Toxicol. 2016 Oct;12(10):1157-68
pubmed: 27310483
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:36-44
pubmed: 29777729
Clin Psychopharmacol Neurosci. 2018 Feb 28;16(1):1-6
pubmed: 29397661
World J Biol Psychiatry. 2013 Jul;14(5):334-85
pubmed: 23879318
Clin Psychopharmacol Neurosci. 2019 Nov 20;17(4):495-502
pubmed: 31671486
Clin Psychopharmacol Neurosci. 2018 Nov 30;16(4):469-480
pubmed: 30466219
Pharmacogenomics J. 2016 Aug;16(4):393-8
pubmed: 26261062
J Genet Couns. 2014 Apr;23(2):156-63
pubmed: 23793969
Psychosomatics. 2006 Jan-Feb;47(1):75-85
pubmed: 16384813
Can J Psychiatry. 2001 Jun;46 Suppl 1:38S-58S
pubmed: 11441771
J Psychopharmacol. 2008 Jun;22(4):343-96
pubmed: 18413657
Mayo Clin Proc. 2016 Jul;91(7):897-907
pubmed: 27289413
Pharmacogenet Genomics. 2013 Oct;23(10):535-48
pubmed: 24018772
Pharmacogenet Genomics. 2017 Jan;27(1):1-6
pubmed: 27779571
Transl Psychiatry. 2012 Oct 16;2:e172
pubmed: 23047243
Prim Care Companion CNS Disord. 2015 Apr 16;17(2):
pubmed: 26445691
Discov Med. 2013 Nov;16(89):219-27
pubmed: 24229738
Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):150-6
pubmed: 26243841